Schonfeld Strategic Advisors LLC Senseonics Holdings, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.55 - $0.89 $72,655 - $117,569	132,100 New	132,100 $100,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.34 $198,196 - $276,649	-206,455 Reduced 94.62%	11,745 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.02 - $2.23 $222,564 - $486,586	218,200 New	218,200 $288,000
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.94 $27,636 - $57,036	-29,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $13,706 - $33,019	8,900 Added 43.41%	29,400 $58,000
Q2 2021 Aug 16, 2021	BUY	$1.71 - $4.14 $35,055 - $84,870	20,500 New	20,500 $79,000
Q3 2018 Nov 14, 2018	SELL	$3.4 - $4.84 $151,980 - $216,348	-44,700 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.03 - $4.98 $135,441 - $222,606	44,700 New	44,700 $184,000

136

60.1M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $475M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.